国际眼科纵览 ›› 2020, Vol. 44 ›› Issue (5): 362-365.doi: 10.3760/ cma.j.issn.1673-5803.2020.05.012

• 综述 • 上一篇    下一篇

干扰素-γ诱导的单核因子与甲状腺相关眼病的关系

仝飞 陈欣欣 牟旆 魏锐利   

  1. 海军军医大学附属长征医院眼科,上海200003
  • 收稿日期:2020-03-11 出版日期:2020-10-22 发布日期:2020-11-01
  • 通讯作者: 魏锐利,Email:ruiliwei@126.com
  • 基金资助:

    国家自然科学基金(81770959)

Monokine induced by interferon-γ and thyroid associated ophthalmopathy

Tong Fei, Chen Xinxin, Mou Pei, Wei Ruili   

  1. Department of Ophthalmology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
  • Received:2020-03-11 Online:2020-10-22 Published:2020-11-01
  • Contact: Wei Ruili, Email: ruiliwei@126.com
  • Supported by:
     National Natural Science Foundation of China (81770959)

摘要:

干扰素-γ诱导的单核因子(monokine induced by interferon-γ,MIG)是一种由干扰素-γ诱导的T细胞趋化因子,在多种特异性自身免疫性疾病中,MIG在组织中高表达和血清中高水平。甲状腺相关眼病(thyroid associated ophthalmopathy,TAO)患者中,在IFN-γ和TNF-α的共同影响下,眼眶成纤维细胞(orbital fibroblasts,OF)和前脂肪细胞分泌MIG。TAO的活动性与循环MIG的存在有关,眼眶炎症的活动,至少可以部分通过MIG浓度的增加来反映。在糖皮质激素治疗期间,与对照组和TAO患者的基准值相比,MIG浓度显著降低。由于目前TAO具体发病机制尚不明确,所以需要继续研究TAO发病机制中趋化因子和细胞因子之间的相互作用。(国际眼科纵览,2020, 44:362-365)

关键词: 干扰素-γ诱导的单核因子, 甲状腺相关眼病, 自身免疫

Abstract:

Monokine induced by interferon-γ(MIG)is a T-cell chemotactic factor induced by interferon-γ. In many specific autoimmune diseases, MIG is highly expressed in tissue and in serum. In patients with thyroid associated ophthalmopathy (TAO), under the combined influence of IFN-γ and TNF-α, the high level of MIG is secreted by orbital fibroblasts (OFs) and preadipocytes. The activity of TAO is related to the existence of circulating MIG, and the activity of orbital inflammation can be reflected at least in part by the increase of MIG concentration. During corticosteroid, MIG levels decreased significantly compared with baseline values in control and TAO patients. As the specific pathogenesis of TAO is not clear, it is necessary to continue to study the interaction between chemokines and cytokines in the pathogenesis of TAO.(Int Rev Ophthalmol, 2020, 44:  362-365)

Key words: monokine induced by interferon-γ, thyroid associated ophthalmopathy, autoimmune